Enochian Biosciences, Inc. (ENOB)


Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Enochian Biosciences, Inc. (“Enochian” or the “Company”) (NASDAQ: ENOB). Investors who purchased Enochian securities are encouraged to obtain additional information and assist the investigation.


The investigation concerns whether Enochian and certain of its officers and/or directors have violated federal securities laws.


On May 25, 2022, the Department of Justice announced the arrest of Enochian Biosciences co-founder and inventor Serhat Gumrukçu. Gumrukçu faces charges in a murder-for-hire conspiracy. Following this news, Enochian Biosciences stock dropped 37% that same day.


If you are aware of any facts relating to this investigation or purchased Enochian shares you can assist this investigation. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.